Cargando…

First Indian prospective randomized comparative study evaluating adherence and compliance of postmenopausal osteoporotic patients for daily alendronate, weekly risedronate and monthly ibandronate regimens of bisphosphonates

AIM: The aim of the following study is to evaluate adherence and compliance of postmenopausal osteoporotic patients for different regimens of bisphosphonates (BP). MATERIALS AND METHODS: A prospective observational randomized comparative 1 year study was undertaken to evaluate the adherence/complian...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tandon, Vishal R., Sharma, Sudhaa, Mahajan, Shagun, Mahajan, Annil, Khajuria, Vijay, Gillani, Zahid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955042/ https://www.ncbi.nlm.nih.gov/pubmed/24672203 http://dx.doi.org/10.4103/0976-7800.127788

Ejemplares similares

A rare case of fondaparinux-induced major bleeding in postmenopausal woman prescribed for non-ST segment elevation Ml
por: Tandon, Vishal R., et al.
Publicado: (2013)

Prevalence of vitamin d deficiency among Indian menopausal women and its correlation with diabetes: A first Indian cross sectional data
por: Tandon, Vishal R., et al.
Publicado: (2014)

Antihypertensive drug prescription patterns, rationality, and adherence to Joint National Committee-7 hypertension treatment guidelines among Indian postmenopausal women
por: Tandon, Vishal R., et al.
Publicado: (2014)

Effect of life-style modification on postmenopausal overweight and obese Indian women: A randomized controlled 24 weeks preliminary study
por: Tandon, Vishal R., et al.
Publicado: (2014)

Bisphosphonate drug holidays: Can we recommend currently?
por: Tandon, Vishal R., et al.
Publicado: (2014)

Zidovudine-induced nail hyper-pigmentation in 45-year-old women prescribed for HIV/tuberculosis co-infection
por: Tandon, Vishal R., et al.
Publicado: (2016)

Obesity: Friend or foe for osteoporosis
por: Sharma, Sudhaa, et al.
Publicado: (2014)

Angioedema due to fixed dose combination of telmisartan plus ramipril
por: Tandon, Vishal R., et al.
Publicado: (2014)

Prevalence of cardiovascular risk factors in postmenopausal women: A rural study
por: Tandon, Vishal R., et al.
Publicado: (2010)

Cilnidipine induced ankle edema
por: Annil, Vishal R., et al.
Publicado: (2014)

Drug-induced diseases (DIDs): An experience of a tertiary care teaching hospital from India
por: Tandon, Vishal R., et al.
Publicado: (2015)

Authors’ response
por: Tandon, Vishal R., et al.
Publicado: (2016)

Fatal adverse drug reactions: Experience of adverse drug reactions in a tertiary care teaching hospital of North India - A case series
por: Tandon, Vishal R., et al.
Publicado: (2014)

A Prospective, Randomized, Open-Label Study Comparing the Efficacy and Safety of Clonazepam versus Nortriptyline on Quality of Life in 40+ Years old Women Presenting with Restless Leg Syndrome
por: Roshi,, et al.
Publicado: (2018)

Comparative Efficacy and Safety of Clonazepam versus Nortriptyline in Restless Leg Syndrome among Forty Plus Women: A Prospective, Open-Label Randomized Study
por: Roshi,, et al.
Publicado: (2019)

Comparative Efficacy and Safety of Clonazepam versus Nortrptilline on Menopausal Symptom among Forty Plus Women: A Prospective, Open-Label Randomized Study
por: Roshi,, et al.
Publicado: (2020)

Comparative evaluation of efficacy and safety of combination of metformin-vidagliptin versus metfromin-glimepiride in most frequently used doses in patients of type 2 diabetes mellitus with inadequately controlled metformin monotherapy-A randomised open label study
por: Gupta, Shallini, et al.
Publicado: (2015)

Comparison of Monthly Ibandronate Versus Weekly Risedronate in Preference, Convenience, and Bone Turnover Markers in Korean Postmenopausal Osteoporotic Women
por: Chung, Yoon-Sok, et al.
Publicado: (2009)

Pregabalin-induced self-harm behavior
por: Tandon, Vishal R, et al.
Publicado: (2013)

Bleomycin Containing Chemotherapeutic Regimen Induced Acquired Partial Lipodystrophy
por: Tandon, Vishal R, et al.
Publicado: (2016)

Calcitonin gene-related peptide and menopause
por: Sharma, Sudhaa, et al.
Publicado: (2010)

Menopause and Sleep Disorders
por: Tandon, Vishal R., et al.
Publicado: (2022)

To evaluate efficacy and safety of Caralluma fimbriata in overweight and obese patients: A randomized, single blinded, placebo control trial
por: Arora, Ekta, et al.
Publicado: (2015)

Does Coronavirus Disease 2019 Kill More Elderly Men than Women Due to Different Hormonal Milieu
por: Tandon, Apurva, et al.
Publicado: (2022)

Authors’ response
por: Tandon, Vishal R., et al.
Publicado: (2015)

Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis
por: Bauss, Frieder, et al.
Publicado: (2006)

Under-reporting of adverse drug reactions: A challenge for pharmacovigilance in India
por: Tandon, Vishal R., et al.
Publicado: (2015)

The role of counselling and other factors in compliance of postmenopausal osteoporotic patients to alendronate 70 therapy
por: Sewerynek, Ewa, et al.
Publicado: (2013)

Cost-effectiveness of teriparatide compared with alendronate and risedronate for the treatment of postmenopausal osteoporosis patients in Iran
por: Ebadi Fard Azar, Amir Ali, et al.
Publicado: (2017)

Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: The risedronate and alendronate (REAL) cohort study
por: Silverman, S. L., et al.
Publicado: (2006)

Osteoprotegerin genetic polymorphisms and their influence on therapeutic response to ibandronate in postmenopausal osteoporotic females
por: Tariq, Saba, et al.
Publicado: (2023)

Effect of Sequential Treatment with Bisphosphonates After Teriparatide in Ovariectomized Rats: A Direct Comparison Between Risedronate and Alendronate
por: Yano, Tetsuo, et al.
Publicado: (2017)

Comparative Efficacy and Safety of Escitalopram versus Desvenlafaxine in Postmenopausal Women with Depression and Anxiety: A Randomized, Open-Label, Comparative Trial
por: Mahajan, Sonia Shinde, et al.
Publicado: (2019)

Dynamic Effects of the Third Generation Bisphosphonate of Risedronate on Rat Osteoporotic Fractures for Clinical Usage Guidance
por: Ke, Cheng‐hui, et al.
Publicado: (2021)

Improvement in Quality of Life of Postmenopausal Women with Depression with commonly used Antidepressants (Escitalopram vs. Desvenlafaxine): A Randomized Controlled Trial in a Tertiary Care Teaching Hospital of North India
por: Mahajan, Sonia Shinde, et al.
Publicado: (2022)

A prospective comparative study of intravenous alendronate and ibandronate for the treatment of osteoporosis
por: Horikawa, Akira, et al.
Publicado: (2019)

Effect of Ibandronate Therapy on Serum Chemerin, Vaspin, Omentin-1 and Osteoprotegerin (OPG) in Postmenopausal Osteoporotic Females
por: Tariq, Saba, et al.
Publicado: (2022)

Efficacy, safety, and compliance of ibandronate treatment for 3 years in postmenopausal Japanese women with primary osteoporosis
por: Suzuki, Takako, et al.
Publicado: (2018)

Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis
por: Moro-Álvarez, María J, et al.
Publicado: (2008)

Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment
por: Derman, Richard, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_9j9f7qma20r00kjnadlj0jkaea